Skip to content
  • Find a Doctor »
open
x
  • Neuronetics
    • Solutions
    • Investors
      • Overview
      • Stock Information
      • News & Events
      • Financial Information
      • Corporate Governance
      • Investor Resources
    • Meet the Team
    • News
    • Careers
  • For Patients
  • For Physicians
  • For Patients
  • For Physicians
  • Neuronetics
  • Why NeuroStar
  • About NeuroStar
  • Patient Corner
  • Insurance
  • About NeuroStar
  • Technology
  • Practice Support
  • Insurance
  • Solutions
  • Investors
  • Meet the Team
  • News
  • Careers
  • Contact Us
  • Global Sites
    • English
    • Deutsch
    • 日本語
    • 한국어
  • How it Works
  • Safety & Tolerability
  • Is it Right for You?
  • Clinical Results
  • Proven Efficacy
  • Safety
  • Mechanism of Action
  • The Key Role
  • Qualified Candidates
  • Scientific Publications
  • Unique Coil
  • TrakStar
  • MT Assist
  • Contact Sensing Advantage
  • Practice Setting
  • Physician Experiences
  • Success Program
  • Clinical Training
  • Field Service
  • Patient Education
  • Public Relations
  • Providers
  • Events and Exhibits
  • Coding and Billing
  • Medical Coverage Policies
  • Health Insurance Coverage
  • Services
  • Resources
  • Neuronetics Board
  • Precision
  • Facts vs Myths
  • About Depression
  • Overview
  • Stock Information
  • News & Events
  • Financial Information
  • Corporate Governance
  • Investor Resources

NeuroStar® in the News

Featured News

  • Find Us On
  • social
  • social
  • social
  • social
  • Press Coverage
  • Press Release
  • Press Contact
  • 12/03/2018
    Woman Battling Chronic Depression Shares Her New Hope Regarding New Treatment
    Mountain Democrat
  • 12/01/2018
    Seasonal Affective Disorder: Not Just The Winter Blues
    Psych Central
  • 11/26/2018
    Dealing With Holiday Depression? You Don't Have To Suffer Alone
    Forbes
  • 11/21/2018
    Rogers Behavioral Health Expands In Electromagnetic Treatment For Depression
    Milwaukee Business Journal

Indication
NeuroStar TMS Therapy is indicated for the treatment of Major Depressive Disorder in adult patients who have failed to receive satisfactory improvement from prior antidepressant medication in the current episode.

NeuroStar TMS Therapy is only available by prescription. A doctor can help decide if NeuroStar TMS Therapy is right for you.

Important Safety Information
The most common side effect is pain or discomfort at or near the treatment site. These events are transient; they occur during the TMS treatment course and do not occur for most patients after the first week of treatment. There is a rare risk of seizure associated with the use of NeuroStar TMS (<0.1% per patient).

NeuroStar TMS Therapy should not be used with patients who have non-removable conductive metal in or near the head. NeuroStar TMS Therapy has not been studied in patients who have not received prior antidepressant treatment.
Safety and Prescribing Information »

Our Commitment
Neuronetics is committed to compliance with state and federal laws regarding interaction with healthcare providers.
Commitment to Compliance »

  • Neuronetics Resources
    • Solutions
    • Investors
    • Team
    • Careers
    • Find a Doctor
  • About NeuroStar
    • Patients
    • Healthcare providers
    • Contact Us
    • In the News
    • Prescribing Information
  • International
    • English
    • Deutsch
    • 日本語
    • 한국어
  • Website
    • Sitemap
    • Glossary
    • References
    • Privacy Policy
    • Terms & Conditions
  • Contact Us
    • 1-877-600-7555
    • Facebook
    • Twitter
    • Instagram
    • YouTube
    • LinkedIn

Copyright @ 2018 Neuronetics. All Rights Reserved.